SYRACUSE, N.Y. — An Ithaca firm won the top funding prize at FuzeHub’s commercialization competition during the New York State Innovation Summit held Monday and Tuesday at the Nicholas J. Pirro Convention Center at Oncenter in Syracuse.
In addition, a business that has operations at the CNY Biotech Accelerator in Syracuse also won a funding award as well.
Anova Biomedical of Ithaca won the first-place prize of $150,000, and Triton Bio of Syracuse was among five companies winning $50,000.
(Sponsored)
CECL Accounting Standard: What You Need to Know
The Financial Accounting Standards Board Accounting Standards Codification (FASB ASC) 326, Financial Instruments-Credit Losses, became effective for all entities on January 1, 2023. This accounting standard introduces the current expected
10 Reasons Your Business Needs Cyber Insurance
1. Cyber crime is the fastest growing crime in the world, but most attacks are not covered by standard property or crime insurance policies. New crimes are emerging every day.
FuzeHub, an Albany–based nonprofit, connects New York’s small and mid-sized manufacturing companies to the resources, programs, and expertise they need for technology commercialization, innovation, and business growth.
The competition occurs yearly as part of the Empire State Development-supported FuzeHub Jeff Lawrence Innovation Fund.
This year, FuzeHub used additional funding from Gov. Kathy Hochul’s office to award funding to even more startups and introduce a runner-up level as well.
A total of 12 entrepreneurs from across New York state competed for a chance to win $50,000 by pitching their business plans to a panel of judges, with a grand prize award of $150,000.
The Anova Biomedical product
Anova Biomedical is developing a vascular graft that will “revolutionize the standard of care” for patients, per the description in the FuzeHub announcement.
“When an artery is blocked, rerouting blood flow with a vascular graft (or blood vessel replacement) can save patient lives and limbs. Vascular grafts used in hospitals today are made using materials that stay in the body forever, causing problems like infection, clot formation, and inflammation. Each of these problems causes pain and suffering for the patient, requires frequent medical intervention, and puts lives at risk. Anova grafts are made using an entirely new material that is infection resistant and prevents clot formation,” as described by FuzeHub.
The Triton Bio product
Imagine having a front-row seat to the hidden drama of microbial life – that’s what Triton Bio delivers, per the FuzeHub announcement. Its newly launched Mira Smart Incubator captures microorganisms “in action and in stunning detail” over days or even weeks.
Using the Mira system, microbiologists will “gain an unprecedented view into the dynamic world” of microorganisms.
“With this revolutionary product, microbiologists will discover new antibiotics and probiotics, improve food preservation and safety measures, engineer microbes that clean up pollution or produce sustainable materials, and optimize brewing and fermentation processes,” as described in the FuzeHub news release.
